| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |